Literature DB >> 9525272

Induction and localization of cytochrome P450 1B1 (CYP1B1) protein in the livers of TCDD-treated rats: detection using polyclonal antibodies raised to histidine-tagged fusion proteins produced and purified from bacteria.

N J Walker1, F G Crofts, Y Li, S F Lax, C L Hayes, P T Strickland, G W Lucier, T R Sutter.   

Abstract

Knowledge of the response of cytochrome P450 1B1 (CYP1B1) to exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in both humans and rodents is limited. To improve the analysis of CYP1 proteins, specific CYP1B1 and CYP1A1 polypeptides were expressed as hexahistidine-tagged fusion proteins in Escherichia coli, purified to homogeneity and used to produce polyclonal antibodies in rabbits. Immunoblot analyses showed that these antibodies were specific and sensitive, detecting both the human and rat forms of the respective isozymes and exhibiting negligible cross-reactivity between the two known CYP1 subfamilies. We show that CYP1B1, CYP1A1 and CYP1A2 protein levels were induced in the livers of female Sprague-Dawley rats following either acute (single dose of 25 microg TCDD/kg) or chronic (125 ng TCDD/kg/day for 30 weeks) exposure to TCDD. CYP1B1 protein exhibited a dose-response to TCDD that was different from those of CYP1A1 and CYP1A2. CYP1B1 induction appeared to be less sensitive to TCDD exposure, with induction occurring at higher doses of TCDD than that required for induction of CYP1A1 or CYP1A2. Immunohistochemical analysis showed that in animals chronically exposed to TCDD (35 ng/kg/day for 30 weeks), CYP1B1 was induced only in centrilobular hepatocytes, a pattern of expression similar to that of CYP1A1 and CYP1A2. These observations of cellular co-localization of the CYP1 cytochromes in livers of TCDD-treated rats and apparent differences in both protein amounts and dose-response are indicative of both common and unique regulation of CYP1 induction.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525272     DOI: 10.1093/carcin/19.3.395

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  6 in total

1.  Complexities in understanding the nature of the dose-response for dioxins and related compounds.

Authors:  Nigel J Walker; Jae-Ho Yang
Journal:  Dose Response       Date:  2006-05-01       Impact factor: 2.658

2.  Computational experiments reveal plausible mechanisms for changing patterns of hepatic zonation of xenobiotic clearance and hepatotoxicity.

Authors:  Shahab Sheikh-Bahaei; Jacquelyn J Maher; C Anthony Hunt
Journal:  J Theor Biol       Date:  2010-06-10       Impact factor: 2.691

3.  A novel 4 S [3H]beta-naphthoflavone-binding protein in liver cytosol of female Sprague-Dawley rats treated with aryl hydrocarbon receptor agonists.

Authors:  D Brauze; D Malejka-Giganti
Journal:  Biochem J       Date:  2000-05-01       Impact factor: 3.857

4.  CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinoma.

Authors:  Mostafizur Rahman; Sigurd F Lax; Carrie H Sutter; Quynh T Tran; Gaylene L Stevens; Gary L Emmert; Jose Russo; Richard J Santen; Thomas R Sutter
Journal:  Drug Metab Dispos       Date:  2008-02-06       Impact factor: 3.922

5.  Reversal of obesity and liver steatosis in mice via inhibition of aryl hydrocarbon receptor and altered gene expression of CYP1B1, PPARα, SCD1, and osteopontin.

Authors:  Itzel Y Rojas; Benjamin J Moyer; Carol S Ringelberg; Craig R Tomlinson
Journal:  Int J Obes (Lond)       Date:  2020-01-07       Impact factor: 5.095

6.  CYP1B1 Augments the Mesenchymal, Claudin-Low, and Chemoresistant Phenotypes of Triple-Negative Breast Cancer Cells.

Authors:  Paul R Hollis; Robert J Mobley; Jyoti Bhuju; Amy N Abell; Carrie Hayes Sutter; Thomas R Sutter
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.